BACKGROUND: Artificial Intelligence (AI) is increasingly used for process management in daily life. In the medical field AI is becoming part of computerized systems to manage information and encourage the generation of evidence. Here we present the development of the application of AI to IT systems present in the hospital, for the creation of a DataMart for the management of clinical and research processes in the field of breast cancer. MATERIALS AND METHODS: A multidisciplinary team of radiation oncologists, epidemiologists, medical oncologists, breast surgeons, data scientists, and data management experts worked together to identify relevant data and sources located inside the hospital system. Combinations of open-source data science packages and industry solutions were used to design the target framework. To validate the DataMart directly on real-life cases, the working team defined tumoral pathology and clinical purposes of proof of concepts (PoCs). RESULTS: Data were classified into "Not organized, not 'ontologized' data", "Organized, not 'ontologized' data", and "Organized and 'ontologized' data". Archives of real-world data (RWD) identified were platform based on ontology, hospital data warehouse, PDF documents, and electronic reports. Data extraction was performed by direct connection with structured data or text-mining technology. Two PoCs were performed, by which waiting time interval for radiotherapy and performance index of breast unit were tested and resulted available. CONCLUSIONS: GENERATOR Breast DataMart was created for supporting breast cancer pathways of care. An AI-based process automatically extracts data from different sources and uses them for generating trend studies and clinical evidence. Further studies and more proof of concepts are needed to exploit all the potentials of this system.
BACKGROUND: Artificial Intelligence (AI) is increasingly used for process management in daily life. In the medical field AI is becoming part of computerized systems to manage information and encourage the generation of evidence. Here we present the development of the application of AI to IT systems present in the hospital, for the creation of a DataMart for the management of clinical and research processes in the field of breast cancer. MATERIALS AND METHODS: A multidisciplinary team of radiation oncologists, epidemiologists, medical oncologists, breast surgeons, data scientists, and data management experts worked together to identify relevant data and sources located inside the hospital system. Combinations of open-source data science packages and industry solutions were used to design the target framework. To validate the DataMart directly on real-life cases, the working team defined tumoral pathology and clinical purposes of proof of concepts (PoCs). RESULTS: Data were classified into "Not organized, not 'ontologized' data", "Organized, not 'ontologized' data", and "Organized and 'ontologized' data". Archives of real-world data (RWD) identified were platform based on ontology, hospital data warehouse, PDF documents, and electronic reports. Data extraction was performed by direct connection with structured data or text-mining technology. Two PoCs were performed, by which waiting time interval for radiotherapy and performance index of breast unit were tested and resulted available. CONCLUSIONS: GENERATOR Breast DataMart was created for supporting breast cancer pathways of care. An AI-based process automatically extracts data from different sources and uses them for generating trend studies and clinical evidence. Further studies and more proof of concepts are needed to exploit all the potentials of this system.
Entities:
Keywords:
DataMart; breast cancer; healthcare; predictive model; real world data
Authors: Philippe Lambin; Erik Roelofs; Bart Reymen; Emmanuel Rios Velazquez; Jeroen Buijsen; Catharina M L Zegers; Sara Carvalho; Ralph T H Leijenaar; Georgi Nalbantov; Cary Oberije; M Scott Marshall; Frank Hoebers; Esther G C Troost; Ruud G P M van Stiphout; Wouter van Elmpt; Trudy van der Weijden; Liesbeth Boersma; Vincenzo Valentini; Andre Dekker Journal: Radiother Oncol Date: 2013-08-28 Impact factor: 6.280
Authors: Gabriele Schnapper; Lorenza Marotti; Denise Casella; Maria P Mano; Robert E Mansel; Antonio Ponti Journal: Breast J Date: 2018-04-23 Impact factor: 2.431
Authors: Luca Tagliaferri; György Kovács; Rosa Autorino; Ashwini Budrukkar; Jose Luis Guinot; Guido Hildebrand; Bengt Johansson; Rafael Martìnez Monge; Jens E Meyer; Peter Niehoff; Angeles Rovirosa; Zoltàn Takàcsi-Nagy; Nicola Dinapoli; Vito Lanzotti; Andrea Damiani; Tamer Soror; Vincenzo Valentini Journal: J Contemp Brachytherapy Date: 2016-08-26
Authors: Thomas Schaffter; Diana S M Buist; Christoph I Lee; Yaroslav Nikulin; Dezso Ribli; Yuanfang Guan; William Lotter; Zequn Jie; Hao Du; Sijia Wang; Jiashi Feng; Mengling Feng; Hyo-Eun Kim; Francisco Albiol; Alberto Albiol; Stephen Morrell; Zbigniew Wojna; Mehmet Eren Ahsen; Umar Asif; Antonio Jimeno Yepes; Shivanthan Yohanandan; Simona Rabinovici-Cohen; Darvin Yi; Bruce Hoff; Thomas Yu; Elias Chaibub Neto; Daniel L Rubin; Peter Lindholm; Laurie R Margolies; Russell Bailey McBride; Joseph H Rothstein; Weiva Sieh; Rami Ben-Ari; Stefan Harrer; Andrew Trister; Stephen Friend; Thea Norman; Berkman Sahiner; Fredrik Strand; Justin Guinney; Gustavo Stolovitzky; Lester Mackey; Joyce Cahoon; Li Shen; Jae Ho Sohn; Hari Trivedi; Yiqiu Shen; Ljubomir Buturovic; Jose Costa Pereira; Jaime S Cardoso; Eduardo Castro; Karl Trygve Kalleberg; Obioma Pelka; Imane Nedjar; Krzysztof J Geras; Felix Nensa; Ethan Goan; Sven Koitka; Luis Caballero; David D Cox; Pavitra Krishnaswamy; Gaurav Pandey; Christoph M Friedrich; Dimitri Perrin; Clinton Fookes; Bibo Shi; Gerard Cardoso Negrie; Michael Kawczynski; Kyunghyun Cho; Can Son Khoo; Joseph Y Lo; A Gregory Sorensen; Hwejin Jung Journal: JAMA Netw Open Date: 2020-03-02